RT Journal Article
SR Electronic
T1 Non-pharmacological measures for the treatment of iron deficiency anemia: A systematic review and meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.23.22274204
DO 10.1101/2022.04.23.22274204
A1 Brasileiro Gomes, Francisca Mayara
A1 Nogueira Arcanjo, Francisco Plácido
A1 Fonteles Moreira, Francisco Leandro
A1 Holanda Cunha Barreto, Ivana Cristina de
A1 de Andrade, Luiz Odorico Monteiro
A1 de Oliveira, Thiago Corrêa
A1 Vellozo, Eliana Pereira
A1 Kopelman, Benjamin Israel
A1 Arcanjo Freire, Cecília Costa
A1 Costa Arcanjo, Caio Plácido
A1 Zanetti Passos, Maria Aparecida
YR 2022
UL http://medrxiv.org/content/early/2022/04/27/2022.04.23.22274204.abstract
AB Objective To conduct a systematic review and meta-analysis to evaluate the effectiveness of non-pharmacological measures for the treatment of iron-deficiency anemia (IDA).Data sources MEDLINE (via PubMed), Cochrane library, SciELO/LILACS and EMBASE up to June 2021Study selection and data extraction We identified all randomized controlled trials (RCTs) that used non-pharmacological measures to treat IDA including iron pots/ingots, or food use were included. The outcomes of interest were hemoglobin (Hb) concentrations and prevalence of anemia.Results 479 studies were retrieved from the databases, of which 4 duplicate records were removed. After, all titles and abstracts were reviewed, 23 articles were considered potentially relevant, and were read in full and checked for eligibility. Three articles met all inclusion criteria. We also conducted a manual search for citations and a further 8 records were identified and checked for eligibility. Eleven RCTs were included in this review. Estimates showed that the use of non-pharmacological measures was associated with a statistically significant overall increase in mean Hb (MD +0.45 g/dL, 95% CI 0.05 to 0.85, p=0.03). The effect of non-pharmacological measures on the prevalence of IDA was analyzed in only 5 RCTs. Participants in the intervention groups were 2.78 times less likely to suffer from IDA than those in the control groups, OR=2.78, 95% CI 0.93, 8.29, however without significance for the overall effect (p=0.07).Conclusion Non-pharmacological therapies have a positive effect on iron balance, and can a useful adjunct to programs to prevent and treat IDA in at-risk populations. (PROSPERO registration number CRD42021261773).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.GRADEGrading of Recommendations Assessment, Development and EvaluationHbHemoglobinIDIron deficiencyIDAIron-deficiency anemiaMDMean differenceOROdds ratioRCTRandomized clinical trialWHOWorld Health Organization